RELATION OF PRO-INFLAMMATORY MARKERS IN MEN AND WOMEN WITH ONE YEAR OUTCOMES AFTER MYOCARDIAL INFARCTION

RELATION OF PRO-INFLAMMATORY MARKERS IN MEN AND WOMEN WITH ONE YEAR OUTCOMES AFTER MYOCARDIAL INFARCTION

Aim. The evaluation of the prominence of subclinical nonspecific inflammation in men and women with ST-elevation myocardial infarction (STEMI) with different one year outcomes.Material and methods. Totally 223 patients with STEMI included — 56 (25,1%) women, 167 (74,9%) men. At 10-14 day of hospital...

Full description

Bibliographic Details
Main Authors:	E. V. Tavlueva, O. L. Barbarash
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2015-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	инфаркт миокарда провоспалительные маркеры гендерные отличия
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/163

Similar Items

Proinflammatory cytokines changes in clinical course of acute myocardial infarction
by: O. V. Soldatova, et al.
Published: (2017-04-01)

PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE
by: P. V. Dolotovskaya, et al.
Published: (2015-09-01)

ASSESSMENT OF SYSTEMIC INFLAMMATORY REACTION IN ACUTE MYOCARDIAL INFARCTION: STATUS UPDATE ON THE PROBLEM
by: M. A Kachkovsky, et al.
Published: (2015-09-01)

GENDER SPECIFICS OF THE RISK FACTORS AND RELATION WITH MYOCARDIAL INFARCTION IN PATIENTS OF VARIOUS AGE GROUPS
by: I. N. Suspitsina, et al.
Published: (2016-06-01)

RELEVANCE AND ROLE OF RISK FACTORS IN THE DEVELOPMENT OF MYOCARDIAL INFARCTION
by: Андрей Георгиевич Петров, et al.
Published: (2021-06-01)

TYPE 2 MYOCARDIAL INFARCTION: CLINICAL AND DEMOGRAPHIC FEATURES, LABORATORY AND INSTRUMENTAL ASSOCIATIONS
by: H T Hoang, et al.
Published: (2018-12-01)

ПОЛОВЫЕ ОСОБЕННОСТИ ИЛИ ПРИРОДНЫЕ РАЗЛИЧИЯ? ОСОБЕННОСТИ ЗАПОМИНАНИЯ ИНФОРМАЦИИ У ДЕВУШЕК И ЮНОШЕЙ. ОПТИМИЗАЦИЯ ПРОЦЕССА ЗАПОМИНАНИЯ
by: Анастасия Николаевна Лаврентьева, et al.
Published: (2022-09-01)

GENETIC ASPECTS OF MYOCARDIAL INFARCTION: PROBLEMS AND PERSPECTIVES
by: P. A. Shesternya, et al.
Published: (2012-02-01)

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
by: T. Yu. Mamonova, et al.
Published: (2009-04-01)

ПРОВОСПАЛИТЕЛЬНЫЕ МАРКЕРЫ РАННИХ РЕПРОДУКТИВНЫХ ПОТЕРЬ
by: L. V. Kastsova
Published: (2022-05-01)

Thrombolytic therapy and cardiac free wall rupture in patients with acute myocardial infarction
by: E M Zeltyn-Abramov, et al.
Published: (2009-03-01)

THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION
by: D. P. Sementsov
Published: (2015-12-01)

CARDIAC RUPTURE IN MYOCARDIAL INFARCTION: INCIDENCE AND PREDISPOSING FACTORS (15 YEAR FOLLOW-UP)
by: V. A. Shulman, et al.
Published: (2015-12-01)

CONCEPT OF MEDICAL AND PHARMACEUTICAL CARE FOR MYOCARDIAL INFARCTION AS A PROSPECTIVE FORM OF SERVICE TO THE POPULATION
by: Андрей Георгиевич Петров, et al.
Published: (2021-04-01)

QUALITY OF LIFE OF PATIENTS WITH LOWER LIMB LOSS DUE TO PERIPHERAL ARTERY DISEASE. GENDER INFLUENCE
by: Елена Михайловна Васильченко
Published: (2018-12-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders
by: B. U. Mardanov, et al.
Published: (2015-11-01)

Prognostic importance of dispersion of interval Q-T electrocardiograms in patients with myocardial infarction
by: A. T. Teplyakov, et al.
Published: (2006-03-01)

COMPLEX ASSESSMENT OF RISK FACTORS FOR PRECISE CHOICE OF REVASCULARIZATION STRATEGY IN ST ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY DISEASE
by: R. S. Tarasov, et al.
Published: (2016-02-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

DYNAMICS OF INCIDENCE WITH MYOCARDIAL INFARCTION IN THE POPULATION OF KUZBASS AND THE RUSSIAN FEDERATION FOR THE PERIOD 2011-2019
by: Андрей Георгиевич Петров, et al.
Published: (2022-03-01)

GENDER FEATURES OF THE STRUCTURE OF COLON EPITHELIAL NEOPLASMS
by: Алексей Григорьевич Короткевич, et al.
Published: (2024-03-01)

COMPREHENSIVE ASSESSMENT OF THE MORTALITY OF THE POPULATION OF THE RUSSIAN FEDERATION AND KUZBASS FROM MYOCARDIAL INFARCTION FOR THE PERIOD 2012-2020
by: Андрей Георгиевич Петров, et al.
Published: (2022-03-01)

ATRIAL FIBRILLATION ASSOCIATED WITH MYOCARDIAL INFARCTION OF DIFFERENT LOCALIZATIONS
by: R. Bhattarai, et al.
Published: (2015-09-01)

PROBLEMS OF RATIONAL CHOICE OF MEDICINAL PREPARATIONS IN PATIENTS WITH MYOCARDIAL INFARCTION
by: Николай Владимирович Абрамов, et al.
Published: (2024-02-01)

INFLAMMATORY REACTIONS IN EXPERIMENTAL MYOCARDIAL DAMAGE
by: L. D. Khidirova, et al.
Published: (2015-12-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS (PART I)
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS. PART II
by: Y. A. Vasyuk, et al.
Published: (2015-12-01)

Endothelial dysfunction and hemostasis in acute myocardial infarction before and after Trombovazim therapy
by: Ye. F. Kotovshchikova, et al.
Published: (2011-02-01)

EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION
by: P. G. Kesov, et al.
Published: (2015-09-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

PARTICULARITĂȚI CLINICE ȘI DE MANAGEMENT ALE PACIENȚILOR CU INFARCT MIOCARDIC FĂRĂ SUPRADENIVELAREA SEGMENTULUI ST CU ARTERE CORONARE NON-OBSTRUCTIVE
by: Olga DICUSAR, et al.
Published: (2024-08-01)

METHODOLOGICAL APPROACH TO MONITORING PHARMACOPROPHYLACTIC MEASURES OF DEVELOPMENT OF MYOCARDIAL INFARCTION BASED ON ASSESSMENT AND PREDICTION OF PSYCHOSOCIAL RISK FACTORS
by: Андрей Георгиевич Петров, et al.
Published: (2021-09-01)

PREDICTORS OF ADVERSE LEFT VENTRICULAR REMODELING IN PATIENTS AFTER MYOCARDIAL INFARCTION
by: E S Zharikova, et al.
Published: (2017-12-01)

OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2
by: K. S. Lexina, et al.
Published: (2015-12-01)

CORONARY COLLATERAL CIRCULATION IN INFARCTION-RELATED ARTERY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH RISE AND WITHOUT RISE OF ST SEGMENT
by: N. A. Yaitsky, et al.
Published: (2018-01-01)

THE LIS STUDY (LYUBERTSY STUDY OF MORTALITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION). EVALUATION OF THE PHARMACOTHERAPY. PART 1. TREATMENT OF PATIENTS BEFORE MYOCARDIAL INFARCTION AND ITS INFLUENCE ON HOSPITAL MORTALITY RATE
by: S. Y. Marcevich, et al.
Published: (2015-12-01)

Problemy ostrogo infarkta miokarda u bol'nykh sakharnym diabetom: ekho Myunkhena
by: Ivan Ivanovich Dedov, et al.
Published: (2008-03-01)

ИНФАРКТ МИОКАРДА ВТОРОГО ТИПА ПРИ ВЫРАЖЕННОМ АОРТАЛЬНОМ СТЕНОЗЕ
by: Алексей Викторович Сизов, et al.
Published: (2022-04-01)

THE EFFECT OF INTENSIVE GLYCEMIC CONTROL ON THE FACTORS DETERMINING PREDICTION COMPLICATIONS OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES
by: A. I. Fedotova, et al.
Published: (2015-10-01)